The US Medical Director for COPD Biologics at AstraZeneca provides medical leadership for the company's initiatives in chronic obstructive pulmonary disease. The role requires a physician or pharmacist with substantial expertise in pulmonary medicine and experience in clinical development, focusing on strategic medical planning and external engagement
Job Summary
This role serves as the primary US medical point of accountability for scientific strategy and evidence generation for COPD biologics.
The position involves leading late-stage clinical development, launch readiness, and post-approval medical excellence for a novel Interleukin-33 targeting monoclonal antibody.
Candidates will benefit from a competitive base pay range of $200,693 to $275,000 USD along with short-term incentives and equity-based long-term programs.
Matching Summary
Match Score: 85
The US Medical Director for COPD Biologics at AstraZeneca provides medical leadership for the company's initiatives in chronic obstructive pulmonary disease. The role requires a physician or pharmacist with substantial expertise in pulmonary medicine and experience in clinical development, focusing on strategic medical planning and external engagement.